Corrigendum to "PARP inhibitors in gliomas: Mechanisms of action, current trends and future perspectives" [Cancer Treat. Rev. 131 (2024) 102850].

MLA

Cella, Eugenia, et al. “Corrigendum to ‘PARP Inhibitors in Gliomas: Mechanisms of Action, Current Trends and Future Perspectives’ [Cancer Treat. Rev. 131 (2024) 102850].” Cancer Treatment Reviews, vol. 132, Jan. 2025, p. 102866. EBSCOhost, https://doi.org/10.1016/j.ctrv.2024.102866.

APA

Cella, E., Bosio, A., Persico, P., Caccese, M., Padovan, M., Losurdo, A., Maccari, M., Cerretti, G., Ius, T., Minniti, G., Idbaih, A., Sanai, N., Weller, M., Preusser, M., Simonelli, M., & Lombardi, G. (2025). Corrigendum to “PARP inhibitors in gliomas: Mechanisms of action, current trends and future perspectives” [Cancer Treat. Rev. 131 (2024) 102850]. Cancer Treatment Reviews, 132, 102866. https://doi.org/10.1016/j.ctrv.2024.102866

Chicago

Cella, Eugenia, Alberto Bosio, Pasquale Persico, Mario Caccese, Marta Padovan, Agnese Losurdo, Marta Maccari, et al. 2025. “Corrigendum to ‘PARP Inhibitors in Gliomas: Mechanisms of Action, Current Trends and Future Perspectives’ [Cancer Treat. Rev. 131 (2024) 102850].” Cancer Treatment Reviews 132 (January): 102866. doi:10.1016/j.ctrv.2024.102866.